Reconcile back in stock following supply issues

Reconcile back in stock following supply issues

Forte Healthcare Ltd is delighted to announce that Reconcile®, the only licensed fluoxetine for dogs, is now fully back in stock in all veterinary wholesalers in the UK.

The recent temporary supply issue was due to the incredible demand for Reconcile since launch in the UK in 2022, greatly surpassing expectations.

Dr Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said; We realise that the recent supply issues have been very inconvenient so we thank all of our customers for their patience and support during this challenging time. We are confident that our supply issues to date have been resolved and that we have enough stock going forward to meet market demand.”

Reconcile® is indicated as an aid in the treatment of separation-related disorders in dogs in combination with behavioural modification techniques.

Reconcile® is available in 4 sizes: 8mg, 16mg, 32mg, and 64mg tablets to allow dosing of small to large dogs. Tablets are chewable and flavoured for acceptance. Dosing is once daily, and Reconcile® comes in pots of 30 tablets.

To facilitate the required behavioural modification Dr Sarah Heath FRCVS (RCVS and EBVS® European Veterinary Specialist in Behavioural Medicine)  has created the CALM programme, and information on this can be found in the suite of Reconcile® support materials, available from your Forte Territory Manager in hardcopy and as downloads from:

For further information on Reconcile® contact your local Forte Healthcare Territory Manager or email If you have any technical questions about Reconcile, or would like to discuss a case, the Forte Veterinary Team can be reached at

Further information is available in the SPC or from Forte Healthcare Ltd. Forte Healthcare Ltd., Block 3, Unit 9, CityNorth Business Campus, Stamullen, Co. Meath, K32 D990, Ireland. Tel: 01292 800013 (UK). Email: (technical enquiries) or (all other queries). Date of preparation: July 2023.